(S (NP-SBJ (NP Modulation/NN) (PP of/IN (NP (NP the/DT expression/NN) (PP of/IN (NP the/DT IFN-gamma/NN receptor/NN beta-chain/NN))))) (VP controls/VBZ (NP (NP responsiveness/NN) (PP to/TO (NP IFN-gamma/NN)) (PP in/IN (NP human/JJ peripheral/JJ blood/NN T/NN cells/NNS)))) ./.)
(S (NP-SBJ IFN-gamma/NN) (VP has/VBZ (NP (NP potent/JJ (ADJP-COOD (ADJP antiproliferative/JJ) and/CC (ADJP apoptotic/JJ)) effects/NNS) (SBAR *ICH*-14/-NONE-)) (PP in/IN (NP T/NN cells/NNS)) (SBAR-14 (WHNP-15 that/WDT) (S (NP-SBJ *T*-15/-NONE-) (VP are/VBP (ADJP-PRD important/JJ) (PP in/IN (S (NP-SBJ */-NONE-) (VP determining/VBG (NP T/NN cell/NN (NP-COOD (NP development/NN) and/CC (NP polarized/VBN differentiation/NN)))))))))) ./.)
(S (ADVP Therefore/RB) ,/, (NP-SBJ (NP any/DT event/NN) (SBAR (WHNP-16 that/WDT) (S (NP-SBJ *T*-16/-NONE-) (VP enables/VBZ (S (NP-SBJ T/NN cells/NNS) (VP to/TO (VP become/VB (ADJP-PRD less/RBR responsive/JJ (PP to/TO (NP IFN- gamma/NN)))))))))) (VP may/MD (ADVP potentially/RB) (VP alter/VB (NP (NP immune/JJ responsiveness/NN) (PP to/TO (NP Ag/NN))))) ./.)
(S (PP In/IN (NP this/DT work/NN)) ,/, (NP-SBJ we/PRP) (VP show/VBP (SBAR that/IN (S (NP-SBJ (NP human/JJ peripheral/JJ blood/NN T/NN cells/NNS) (SBAR (WHNP-17 that/WDT) (S (NP-SBJ-18 *T*-17/-NONE-) (VP are/VBP (VP-COOD (VP stimulated/VBN (NP *-18/-NONE-) (PP through/IN (NP the/DT TCR/NN))) and/CC (VP expanded/VBN (NP *-18/-NONE-) (PP with/IN (NP IL-2/NN)))))))) (VP are/VBP (ADJP-PRD unresponsive/JJ (PP to/TO (NP IFN-gamma/NN))) ,/, (SBAR as/IN (S (NP-SBJ-19 */-NONE-) (VP determined/VBN (NP *-19/-NONE-) (PP by/IN (NP (NP a/DT lack/NN) (PP of/IN (NP-COOD (NP (NP activation/NN) (PP of/IN (NP-COOD (NP jak/NN kinases/NNS) and/CC (NP (NP the/DT transcription/NN factor/NN) ,/, (NP STAT1-LRB-alpha-RRB-/NN))))) ,/, (NP a/DT signal/NN transducer/NN) and/CC (NP (NP activator/NN) (PP of/IN (NP transcription/NN)))))))))))))) ./.)
(S (NP-SBJ-20 This/DT nonresponsiveness/NN) (VP occurs/VBZ (PP because/IN of/IN (NP (NP a/DT lack/NN) (PP of/IN (NP (NP expression/NN) (PP of/IN (NP (NP (NP the/DT beta- chain/NN) (PRN -LRB-/-LRB- (NP accessory/JJ factor/NN) -RRB-/-RRB-)) (PP of/IN (NP the/DT IFN-gamma/NN receptor/NN)))))))) ,/, (SBAR while/IN (S (PP-TMP at/IN (VP the/DT same/JJ time/NN)) (NP-SBJ *-20/-NONE-) (VP maintaining/VBG (NP IFN-gamma/NN receptor/NN alpha-chain/NN expression/NN))))) ./.)
(S (NP-SBJ-21 (NP Expression/NN) (PP of/IN (NP the/DT beta-chain/NN))) (VP can/MD (VP be/VB (VP restored/VBN (NP *-21/-NONE-) (PP by/IN (NP-LGS-COOD (NP secondary/JJ TCR/NN ligation/NN) or/CC (NP PMA/NN treatment/NN)))))) ./.)
(S (NP-SBJ (NP T/NN cell/NN blasts/NNS) (VP treated/VBN (NP */-NONE-) (PP with/IN (NP PMA/NNS)))) (VP are/VBP (ADVP-TMP now/RB) (ADJP-PRD responsive/JJ (PP to/TO (NP IFN-gamma/NN)))) ./.)
(S (S (SBAR-TMP (WHADVP-24 When/WRB) (S (NP-SBJ-23 *-25/-NONE-) (ADVP freshly/RB) (VP isolated/VBN (NP *-23/-NONE-) (ADVP *T*-24/-NONE-)))) ,/, (NP-SBJ-22 (ADJP (ADJP highly/RB enriched/VBN) (PRN -LRB-/-LRB- (NP (QP &gt;/JJR 98/CD) %/NN) -RRB-/-RRB-)) T/NN cells/NNS) (VP are/VBP (VP examined/VBN (NP-25 *-22/-NONE-) (PP for/IN (NP IFN-gamma/NN responsiveness/NN)))) ;/:) (S (NP-SBJ these/DT cells/NNS) (VP can/MD (VP-COOD (VP respond/VB (PP to/TO (NP IFN-gamma/NN))) and/CC (VP express/VB (NP beta-chain/NN)))) ./.))
(S (ADVP Therefore/RB) ,/, (SBAR as/IN (S (NP-SBJ T/NN cells/NNS) (VP progress/VBP (PP from/IN (NP primary/JJ TCR/NN activation/NN)) (PP through/IN (NP IL-2-dependent/JJ proliferation/NN)) ,/, (S (NP-SBJ-26 */-NONE-) (VP followed/VBN (NP *-26/-NONE-) (PP by/IN (NP secondary/JJ TCR/NN stimulation/NN))))))) ,/, (S-COOD (S (NP-SBJ (NP their/PRP$ responsiveness/NN) (PP to/TO (NP IFN-gamma/NN))) (VP varies/VBZ)) ,/, and/CC (S (NP-SBJ this/DT) (VP may/MD (VP affect/VB (NP their/PRP$ ability/NN (S (NP-SBJ */-NONE-) (VP to/TO (VP participate/VB (PP in/IN (NP an/DT ongoing/JJ immune/JJ response/NN)))))))))) ./.)
